Keap1âNrf2 pathway: A promising target towards lung cancer prevention and therapeutics
Objectives: Drugs for targeted therapy have become a new strategy of adjuvant therapy for treatment of lung cancer. The Keap1 (kelch-like ECH-associated protein 1)âNrf2 (nuclear factor erythroid 2-related factor 2) pathway is recognized to be critical in regulating genes related to the cellular prot...
Main Authors: | Ying-Hui Tong, Bo Zhang, Yun Fan, Neng-Ming Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2015-09-01
|
Series: | Chronic Diseases and Translational Medicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095882X15000535 |
Similar Items
-
The Keap1/Nrf2-ARE Pathway as a Pharmacological Target for Chalcones
by: Matheus de Freitas Silva, et al.
Published: (2018-07-01) -
Keap1/Nrf2 Signaling Pathway
by: Gerasimos P. Sykiotis
Published: (2021-05-01) -
Targeting the Nrf2/Keap1 interaction
by: Steel, Richard James
Published: (2014) -
The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus
by: Joshua A. David, et al.
Published: (2017-01-01) -
Marburgvirus Hijacks Nrf2-Dependent Pathway by Targeting Nrf2-Negative Regulator Keap1
by: Audrey Page, et al.
Published: (2014-03-01)